当前位置:首页 - 行情中心 - 天山生物(300313) - 财务分析 - 现金流量表

天山生物

(300313)

  

流通市值:19.54亿  总市值:23.74亿
流通股本:1.97亿   总股本:2.40亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金323,439,048.45205,467,178.54105,468,939.26217,698,130.29
  收到其他与经营活动有关的现金8,139,773.742,615,222.13845,721.6343,382,457.18
  经营活动现金流入小计331,578,822.19208,082,400.67106,314,660.89261,080,587.47
  购买商品、接受劳务支付的现金314,533,859.4195,704,482.17109,221,463.58213,662,705.73
  支付给职工以及为职工支付的现金21,371,681.8213,078,534.195,336,192.0718,295,641.55
  支付的各项税费7,868,052.274,905,572.343,504,156.348,563,950.42
  支付其他与经营活动有关的现金9,521,220.15,597,657.13,266,173.4518,611,885.33
  经营活动现金流出小计353,294,813.59219,286,245.8121,327,985.44259,134,183.03
  经营活动产生的现金流量净额-21,715,991.4-11,203,845.13-15,013,324.551,946,404.44
二、投资活动产生的现金流量:
  取得投资收益收到的现金---2,868,420
  处置固定资产、无形资产和其他长期资产收回的现金净额812,852.22786,912.22236,260293,650
  处置子公司及其他营业单位收到的现金净额813,059.56485,124.47--
  投资活动现金流入小计1,625,911.781,272,036.69236,2603,162,070
  购建固定资产、无形资产和其他长期资产支付的现金5,657,670.164,567,221.031,932,3666,183,166.61
  支付其他与投资活动有关的现金--1,066,666716,325.67
  投资活动现金流出小计5,657,670.164,567,221.032,999,0326,899,492.28
  投资活动产生的现金流量净额-4,031,758.38-3,295,184.34-2,762,772-3,737,422.28
三、筹资活动产生的现金流量:
  吸收投资收到的现金980,000980,000980,0002,450,000
  其中:子公司吸收少数股东投资收到的现金980,000980,000980,0002,450,000
  取得借款收到的现金10,000,000---
  收到其他与筹资活动有关的现金20,000,00020,000,00010,200,00073,380,022
  筹资活动现金流入小计30,980,00020,980,00011,180,00075,830,022
  偿还债务支付的现金1,500,0001,500,000-49,700,000
  分配股利、利润或偿付利息支付的现金1,144,898.19736,379.68378,329.684,505,107.17
  支付其他与筹资活动有关的现金25,019,36717,462,4671,400,0004,940,979.25
  筹资活动现金流出小计27,664,265.1919,698,846.681,778,329.6859,146,086.42
  筹资活动产生的现金流量净额3,315,734.811,281,153.329,401,670.3216,683,935.58
五、现金及现金等价物净增加额-22,432,014.97-13,217,876.15-8,374,426.2314,892,917.74
  加:期初现金及现金等价物余额39,392,937.5339,392,937.5339,392,937.5324,500,019.79
  期末现金及现金等价物余额16,960,922.5626,175,061.3831,018,511.339,392,937.53
补充资料:
  净利润-5,322,917.95--26,189,029.43
  资产减值准备-1,325,826.06-10,960,621.22
  固定资产和投资性房地产折旧-3,914,837.7-8,826,223.56
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-3,914,837.7-8,826,223.56
  无形资产摊销-1,460,104.72-3,303,529.74
  长期待摊费用摊销-582,572.68-1,250,497.75
  处置固定资产、无形资产和其他长期资产的损失--131,698.05--81,149.36
  固定资产报废损失-18,674.01-71,428.81
  财务费用-2,909,644.88-9,272,591.39
  投资损失--3,655,352.22--3,387,136.75
  递延所得税--150,771.58-356,898.39
  其中:递延所得税资产减少-370,783.44--560,274.49
    递延所得税负债增加--521,555.02-917,172.88
  存货的减少--15,903,388.74--18,098,289.63
  经营性应收项目的减少--13,108,029.67--14,416,607.24
  经营性应付项目的增加-4,440,149.92-28,709,490.4
  不涉及现金收支的投资和筹资活动金额其他项目---8,089,633.51
  现金的期末余额-26,175,061.38-39,392,937.53
  减:现金的期初余额-39,392,937.53-24,500,019.79
  现金及现金等价物的净增加额--13,217,876.15-14,892,917.74
公告日期2026-10-302026-08-292026-04-252026-04-25
审计意见(境内)带强调事项段的无保留意见
TOP↑